[
  {
    "ts": "2026-01-28T08:09:24+00:00",
    "headline": "Merck Ends Revolution Medicines Talks As Oncology Plans And Valuation Weighed",
    "summary": "Merck paused acquisition discussions with Revolution Medicines after the two sides could not agree on valuation. The halted talks highlight a shift in Merck's approach to expanding its oncology presence as it reassesses potential deals. This development may influence how investors view both Merck's future transactions and broader pharma M&A activity. Merck, traded as NYSE:MRK, enters this chapter with its shares at $107.92 and a 1-year return of 14.9%. Over 5 years, the stock has returned...",
    "url": "https://finance.yahoo.com/news/merck-ends-revolution-medicines-talks-080924264.html",
    "source": "Simply Wall St.",
    "provider": "yfinance",
    "raw": {
      "id": "6b3e3b78-e4c3-3502-9832-47acc04287e5",
      "content": {
        "id": "6b3e3b78-e4c3-3502-9832-47acc04287e5",
        "contentType": "STORY",
        "title": "Merck Ends Revolution Medicines Talks As Oncology Plans And Valuation Weighed",
        "description": "",
        "summary": "Merck paused acquisition discussions with Revolution Medicines after the two sides could not agree on valuation. The halted talks highlight a shift in Merck's approach to expanding its oncology presence as it reassesses potential deals. This development may influence how investors view both Merck's future transactions and broader pharma M&A activity. Merck, traded as NYSE:MRK, enters this chapter with its shares at $107.92 and a 1-year return of 14.9%. Over 5 years, the stock has returned...",
        "pubDate": "2026-01-28T08:09:24Z",
        "displayTime": "2026-01-28T08:09:24Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/simply_wall_st__316/d7ea461ebd942c5c61a3f68254dc45cf",
          "originalWidth": 1194,
          "originalHeight": 432,
          "caption": "",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/kA84g.s9IO2ClCgTX6BCgg--~B/aD00MzI7dz0xMTk0O2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/simply_wall_st__316/d7ea461ebd942c5c61a3f68254dc45cf.cf.webp",
              "width": 1194,
              "height": 432,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/DmY770n7xz5DXLM6ZHLmxA--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/simply_wall_st__316/d7ea461ebd942c5c61a3f68254dc45cf.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "Simply Wall St.",
          "url": "https://simplywall.st/"
        },
        "canonicalUrl": {
          "url": "https://finance.yahoo.com/news/merck-ends-revolution-medicines-talks-080924264.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/merck-ends-revolution-medicines-talks-080924264.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "MRK"
            },
            {
              "symbol": "RVMD"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  },
  {
    "ts": "2026-01-28T12:04:00+00:00",
    "headline": "Global Glioma Market Growth Driven by Therapeutic Innovations and Aging Population",
    "summary": "The Global Glioma Market is focused on managing gliomas, aggressive brain tumors from glial cells. Glioblastoma Multiforme (GBM) is the deadliest type, characterized by rapid growth and invasiveness. Early diagnosis and treatment are crucial for improving patient outcomes. The market is driven by rising glioma cases, advancing cancer therapies, and enhanced diagnostic tools. Challenges include drug resistance, high treatment costs, and complex regulatory issues. Leading companies like Merck & Co",
    "url": "https://finance.yahoo.com/news/global-glioma-market-growth-driven-120400903.html",
    "source": "GlobeNewswire",
    "provider": "yfinance",
    "raw": {
      "id": "84028e1e-fe0c-3746-b3be-cdc043f031e1",
      "content": {
        "id": "84028e1e-fe0c-3746-b3be-cdc043f031e1",
        "contentType": "STORY",
        "title": "Global Glioma Market Growth Driven by Therapeutic Innovations and Aging Population",
        "description": "",
        "summary": "The Global Glioma Market is focused on managing gliomas, aggressive brain tumors from glial cells. Glioblastoma Multiforme (GBM) is the deadliest type, characterized by rapid growth and invasiveness. Early diagnosis and treatment are crucial for improving patient outcomes. The market is driven by rising glioma cases, advancing cancer therapies, and enhanced diagnostic tools. Challenges include drug resistance, high treatment costs, and complex regulatory issues. Leading companies like Merck & Co",
        "pubDate": "2026-01-28T12:04:00Z",
        "displayTime": "2026-01-28T12:04:00Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/globenewswire.com/93d5b27580f67db722dd7c112e43e8bc",
          "originalWidth": 480,
          "originalHeight": 58,
          "caption": "",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/_MlAqEncKPaKK77zrkRGmQ--~B/aD01ODt3PTQ4MDthcHBpZD15dGFjaHlvbg--/https://media.zenfs.com/en/globenewswire.com/93d5b27580f67db722dd7c112e43e8bc.cf.webp",
              "width": 480,
              "height": 58,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/caWFqk489OEmv3xI33JamQ--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/globenewswire.com/93d5b27580f67db722dd7c112e43e8bc.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "GlobeNewswire",
          "url": "https://www.globenewswire.com/"
        },
        "canonicalUrl": {
          "url": "https://finance.yahoo.com/news/global-glioma-market-growth-driven-120400903.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/global-glioma-market-growth-driven-120400903.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "MRK"
            },
            {
              "symbol": "AMGN"
            },
            {
              "symbol": "PFE"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  },
  {
    "ts": "2026-01-28T13:30:00+00:00",
    "headline": "TransCelerate BioPharma Showcases Approaches to Advancing Clinical Trial Efficiency and Patient-Centered Design at SCOPE US 2026",
    "summary": "TransCelerate BioPharma (TransCelerate), a nonprofit organization dedicated to improving the health of people around the world by accelerating and simplifying clinical research, will highlight practical, scalable approaches to advancing more efficient, patient-centered clinical trials across the research lifecycle at SCOPE Summit 2026, taking place February 2-5 in Orlando, Florida.",
    "url": "https://finance.yahoo.com/news/transcelerate-biopharma-showcases-approaches-advancing-133000205.html",
    "source": "PR Newswire",
    "provider": "yfinance",
    "raw": {
      "id": "a4a68708-122d-314f-b901-b231171e04f6",
      "content": {
        "id": "a4a68708-122d-314f-b901-b231171e04f6",
        "contentType": "STORY",
        "title": "TransCelerate BioPharma Showcases Approaches to Advancing Clinical Trial Efficiency and Patient-Centered Design at SCOPE US 2026",
        "description": "",
        "summary": "TransCelerate BioPharma (TransCelerate), a nonprofit organization dedicated to improving the health of people around the world by accelerating and simplifying clinical research, will highlight practical, scalable approaches to advancing more efficient, patient-centered clinical trials across the research lifecycle at SCOPE Summit 2026, taking place February 2-5 in Orlando, Florida.",
        "pubDate": "2026-01-28T13:30:00Z",
        "displayTime": "2026-01-28T13:30:00Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/prnewswire.com/8f1b12e1f864d34950521bd9e92e0b08",
          "originalWidth": 400,
          "originalHeight": 109,
          "caption": "TransCelerate BioPharma (PRNewsfoto/TransCelerate BioPharma)",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/vVswb4M33A3mRhb6Ae6Gog--~B/aD0xMDk7dz00MDA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/prnewswire.com/8f1b12e1f864d34950521bd9e92e0b08.cf.webp",
              "width": 400,
              "height": 109,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/rgzb5Fajr8TOTPYyKl6rFQ--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/prnewswire.com/8f1b12e1f864d34950521bd9e92e0b08.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "PR Newswire",
          "url": "https://www.prnewswire.com/"
        },
        "canonicalUrl": {
          "url": "https://finance.yahoo.com/news/transcelerate-biopharma-showcases-approaches-advancing-133000205.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/transcelerate-biopharma-showcases-approaches-advancing-133000205.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "AMGN"
            },
            {
              "symbol": "MRK"
            },
            {
              "symbol": "PFE"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  }
]